Oral ondansetron (GR38032F) for the control of acute and delayed cyclophosphamide-induced emesis.

MLA

Rosso, R., et al. “Oral Ondansetron (GR38032F) for the Control of Acute and Delayed Cyclophosphamide-Induced Emesis.” Anticancer Research, vol. 11, no. 2, Mar. 1991, pp. 937–39. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=1829602&authtype=sso&custid=ns315887.

APA

Rosso, R., Campora, E., Cetto, G., Fosser, V., Marangolo, M., & Oliva, C. (1991). Oral ondansetron (GR38032F) for the control of acute and delayed cyclophosphamide-induced emesis. Anticancer Research, 11(2), 937–939.

Chicago

Rosso, R, E Campora, G Cetto, V Fosser, M Marangolo, and C Oliva. 1991. “Oral Ondansetron (GR38032F) for the Control of Acute and Delayed Cyclophosphamide-Induced Emesis.” Anticancer Research 11 (2): 937–39. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=1829602&authtype=sso&custid=ns315887.